APS Logo

Personalized radiation attenuating materials for mucosal protection

ORAL

Abstract

Patients receiving radiation therapy will develop normal tissue injury as a result of treatment. If a radiation attenuating material is placed in normal tissues, it may reduce the radiation received by that tissue. In this study, we measured the radiation attenuating properties of different materials. We investigated the dosimetric impact of three patient-specific radioprotective devices: a 3D-printed intra-oral device for oral cavity cancer patients, and balloon catheters with radioprotective liquids in the esophagus and rectum for lung and prostate cancer patients respectively. The oral cavity and rectum devices demonstrated protective properties in retrospective treatment plans, so in vivo application of these devices was tested in a rat model. Rats treated with the protective devices in place showed decreased ulcerations and erythema of the oral and rectal mucosa compared to control animals. Use of radioprotective devices in patients has the potential to reduce the morbidity of radiation treatments for cancer.

Presenters

  • Jennifer Pursley

    Department of Radiation Oncology, Massachusetts General Hospital

Authors

  • James Donald Byrne

    Harvard Radiation Oncology Program

  • Jennifer Pursley

    Department of Radiation Oncology, Massachusetts General Hospital

  • Kyla Remillard

    Department of Radiation Oncology, Massachusetts General Hospital

  • Samantha Edgington

    Department of Radiation Oncology, Massachusetts General Hospital

  • Jonathan D Schoenfeld

    Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital

  • Giovanni Traverso

    Department of Mechanical Engineering, Massachusetts Institute of Technology